Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Disulfiram for Visual Acuity in Retinal Degeneration
NCT06319872Phase 1Recruiting
- Sponsor
- University of Rochester
- Start
- May 2025
- Primary completion
- May 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of disulfiram in retinal degeneration and alcohol use disorder (AUD), sponsored by University of Rochester. Primary endpoint: Best Corrected Visual Acuity at 180 days. Started May 2025; status: recruiting.
02
Drugs
disulfiram
03
Conditions
retinal degenerationalcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT06319872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06319872.